Evli Japan vs UBS Lux Equity Fund Biotech USD
1. Evli Japan
-
Security
Evli Japan
-
Fee
1.62%
-
ISIN
FI0008807722
-
Holdings
1
2. UBS Lux Equity Fund Biotech USD
Fund Holdings
We have information about 2 holdings in Evli Japan, where the largest holding is Inpex (2.05), followed by (0) and (0). In comparison with UBS Lux Equity Fund Biotech USD, we have 7 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66).
All Holdings
Here we compare the holdings in Evli Japan and UBS Lux Equity Fund Biotech USD.
Evli Japan |
UBS Lux Equity Fund Biotech USD |
1. Inpex Corp  2.05 % |
1. Regeneron Pharmaceuticals Inc 10.04 % |
- |
2. Moderna Inc 9.21 % |
- |
3. Gilead Sciences Inc  4.66 % |
- |
4. BioNTech SE 4.13 % |
- |
5. Karuna Therapeutics Inc 3.75 % |
The list of fund holdings was last updated on September 10, 2025.